BioStock - Connecting Innovation and Capital Revenue and Competitors

Lund,

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • BioStock - Connecting Innovation and Capital's estimated annual revenue is currently $1.4M per year.(i)
  • BioStock - Connecting Innovation and Capital's estimated revenue per employee is $84,000

Employee Data

  • BioStock - Connecting Innovation and Capital has 17 Employees.(i)
  • BioStock - Connecting Innovation and Capital grew their employee count by -23% last year.

BioStock - Connecting Innovation and Capital's People

NameTitleEmail/Phone
1
Specialist på digital marknadsföringReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M90-36%$14.1MN/A
#2
$83.2M468-3%$251MN/A
#3
$14M1001%N/AN/A
#4
$14.6M0N/A$12.5MN/A
#5
$30.3M197-6%N/AN/A
#6
$0.1M6-25%$2.6MN/A
#7
$45.1M2932%N/AN/A
#8
$4.8M43-7%N/AN/A
#9
$399.3M203740%N/AN/A
#10
$44M2864%N/AN/A
Add Company

What Is BioStock - Connecting Innovation and Capital?

BioStock is a news and analysis service focused on the Nordic Life Science sector and caters to individuals, organizations and companies. Content published by BioStock may be shared but the source must always be stated. Official information about companies mentioned by BioStock can be found on the respectiv company's website. BioStock is based in Lund, Sweden.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$1.4M

Revenue (est)

-23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioStock - Connecting Innovation and Capital News

2022-04-13 - BioStock: Idogens studie godkänns i Norge och Sverige

BioStock: Idogens studie godkänns i Norge och Sverige ... Detta är ett pressmeddelande från BioStock – Connecting Innovation & Capital.

2022-04-13 - BioStock Studio: PolarCool om företrädesemission och ...

BioStock Studio: PolarCool om företrädesemission och ... Detta är ett pressmeddelande från BioStock – Connecting Innovation & Capital.

2022-03-30 - BioStock: Promore Pharma's phase II study running according to plan

BioStock: Promore Pharma's phase II study running according to plan ... This is a press release from BioStock - Connecting Innovation...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M17-6%N/A
#2
$4.3M17-6%N/A
#3
$1.4M170%N/A
#4
$1.7M19-5%N/A
#5
$3.1M2011%N/A